Studies indicate that in lung cancer cells, ADAM23 interacts with integrin αvβ3 to exert inhibitory effects on cancer progression, suggesting that downregulation of ADAM23 in SP cells may contribute to enhancing the phenotype of tumor stem cells by promoting the activity of integrin αvβ3 (Ota et al., 2016). Here, ADAM23 is linked to lung carcinoma.